The FDA has approved eltrombopag tablets for the treatment idiopathic thrombocytopenic purpura in patients who have had insufficient response to corticosteroids, immunoglobulins or splenectomy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback